214 related articles for article (PubMed ID: 33652817)
1. Neoadjuvant Chemoradiotherapy Followed by Esophagectomy with Three-Field Lymph Node Dissection for Thoracic Esophageal Squamous Cell Carcinoma Patients with Clinical Stage III and with Supraclavicular Lymph Node Metastasis.
Sato Y; Motoyama S; Wada Y; Wakita A; Kawakita Y; Nagaki Y; Terata K; Imai K; Anbai A; Hashimoto M; Minamiya Y
Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33652817
[TBL] [Abstract][Full Text] [Related]
2. Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery.
Cho WK; Oh D; Ahn YC; Shim YM; Zo JI; Sun JM; Ahn MJ; Park K
Oncotarget; 2017 Jan; 8(2):3542-3552. PubMed ID: 27682879
[TBL] [Abstract][Full Text] [Related]
3. Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection.
Chen J; Wu S; Zheng X; Pan J; Zhu K; Chen Y; Li J; Liao L; Lin Y; Liao Z
BMC Surg; 2014 Dec; 14():110. PubMed ID: 25527100
[TBL] [Abstract][Full Text] [Related]
4. A strategy for supraclavicular lymph node dissection using recurrent laryngeal nerve lymph node status in thoracic esophageal squamous cell carcinoma.
Taniyama Y; Nakamura T; Mitamura A; Teshima J; Katsura K; Abe S; Nakano T; Kamei T; Miyata G; Ouchi N
Ann Thorac Surg; 2013 Jun; 95(6):1930-7. PubMed ID: 23642437
[TBL] [Abstract][Full Text] [Related]
5. PET-Uptake Reduction into Lymph Nodes After Neoadjuvant Therapy is Highly Predictive of Prognosis for Patients Who have Thoracic Esophageal Squamous Cell Carcinoma Treated with Chemoradiotherapy Plus Esophagectomy.
Nagaki Y; Motoyama S; Sato Y; Wakita A; Fujita H; Kemuriyama K; Sasaki Y; Imai K; Maeda E; Minamiya Y
Ann Surg Oncol; 2022 Feb; 29(2):1336-1346. PubMed ID: 34355333
[TBL] [Abstract][Full Text] [Related]
6. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
[TBL] [Abstract][Full Text] [Related]
7. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
8. SUV
Nagaki Y; Motoyama S; Sato Y; Wakita A; Fujita H; Sasaki Y; Imai K; Minamiya Y
World J Surg Oncol; 2021 Apr; 19(1):105. PubMed ID: 33836789
[TBL] [Abstract][Full Text] [Related]
9. Significance of dissection in each regional lymph-node station of esophageal cancer based on efficacy index and recurrence patterns after curative esophagectomy.
Kanemura T; Miyata H; Takeoka T; Sugase T; Sugimura K; Yamashita K; Tanaka K; Makino T; Ota M; Yagi K; Toh Y; Seto Y; Doki Y
Esophagus; 2023 Jul; 20(3):402-409. PubMed ID: 36574141
[TBL] [Abstract][Full Text] [Related]
10. Clinical value of lymph node dissection for stage T1b mid-thoracic esophageal squamous cell carcinoma.
Chen X; Chen Y; Wang F; Liu S; Chen P; He H
J Gastrointest Oncol; 2021 Aug; 12(4):1223-1227. PubMed ID: 34532082
[TBL] [Abstract][Full Text] [Related]
11. Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma.
Ni W; Yang J; Deng W; Xiao Z; Zhou Z; Zhang H; Chen D; Feng Q; Liang J; Lv J; Wang X; Wang X; Zhang T; Bi N; Deng L; Wang W
BMC Cancer; 2020 Feb; 20(1):144. PubMed ID: 32087687
[TBL] [Abstract][Full Text] [Related]
12. [Clinical value of para-recurrent laryngeal nerve lymphadenectomy for middle thoracic esophageal squamous cell carcinoma].
Wang Z; Liu S
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Sep; 18(9):867-70. PubMed ID: 26404679
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and prognosis for supraclavicular lymph node metastasis in patients with thoracic esophageal cancer. Distant or regional metastasis?
Shiraishi O; Hagi T; Hiraki Y; Kato H; Koda M; Nakanishi T; Yasuda A; Shinkai M; Imano M; Yasuda T
Dis Esophagus; 2024 May; ():. PubMed ID: 38745437
[TBL] [Abstract][Full Text] [Related]
14. Clinical Importance of Supraclavicular Lymph Node Metastasis After Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
Miyata H; Yamasaki M; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
Ann Surg; 2015 Aug; 262(2):280-5. PubMed ID: 25211269
[TBL] [Abstract][Full Text] [Related]
15. [Associated factors of postoperative relapse and metastasis in pT1bN0M0-pT4aN0M0 thoracic esophageal squamous cell carcinoma].
Pan W; Xiang Y; Gu Z; Ji C; Mao T; Fang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1045-1049. PubMed ID: 28900998
[TBL] [Abstract][Full Text] [Related]
16. Neck Lymph Node Metastasis as A Poor Prognostic Factor in Thoracic Esophageal Squamous Cell Carcinoma Patients Receiving Concurrent Chemoradiotherapy: A Propensity Score-Matched Analysis.
Chen YH; Lu HI; Lo CM; Wang YM; Chou SY; Hsiao CC; Shih LH; Chen SW; Li SH
Sci Rep; 2018 Oct; 8(1):15073. PubMed ID: 30305678
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis.
Nabeya Y; Ochiai T; Matsubara H; Okazumi S; Shiratori T; Shuto K; Aoki T; Miyazaki S; Gunji Y; Uno T; Ito H; Shimada H
Dis Esophagus; 2005; 18(6):388-97. PubMed ID: 16336610
[TBL] [Abstract][Full Text] [Related]
18. Is Thoracic Duct Resection Necessary for Esophageal Squamous Cell Carcinoma Patients Treated with Neoadjuvant Chemoradiotherapy? A Propensity-Matched Analysis Based on the Comprehensive Registry of Esophageal Cancer in Japan.
Oshikiri T; Numasaki H; Oguma J; Toh Y; Watanabe M; Muto M; Kakeji Y; Doki Y
Ann Surg Oncol; 2023 May; 30(5):2691-2698. PubMed ID: 36529778
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic Cervical Lymph Node Dissection in Thoracoscopic Esophagectomy for Esophageal Cancer Increases Postoperative Complications and Does Not Improve Survival.
Koterazawa Y; Oshikiri T; Takiguchi G; Hasegawa H; Yamamoto M; Kanaji S; Yamashita K; Matsuda T; Nakamura T; Fujino Y; Tominaga M; Suzuki S; Kakeji Y
Ann Surg Oncol; 2019 Sep; 26(9):2899-2904. PubMed ID: 31187365
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience.
Chen Y; Hao D; Wu X; Xing W; Yang Y; He C; Wang W; Liu J; Wang J
Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]